Selecting the dosage of ceftazidime-avibactam in the perfect storm of nosocomial pneumonia.

This work serves as a successful practical example of dosage design for a new antibacterial drug therapy in the indication of NP, including VAP, where previous drug therapies have failed, possibly as a result of evaluation of too few variables, thereby limiting the accuracy of pharmacodynamic predictions.